Cargando…

Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.

Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ragozzino, M M, Kuo, A, DeGregori, J, Kohl, N, Ruley, H E
Formato: Texto
Lenguaje:English
Publicado: 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568054/
https://www.ncbi.nlm.nih.gov/pubmed/1837777
_version_ 1782129931299323904
author Ragozzino, M M
Kuo, A
DeGregori, J
Kohl, N
Ruley, H E
author_facet Ragozzino, M M
Kuo, A
DeGregori, J
Kohl, N
Ruley, H E
author_sort Ragozzino, M M
collection PubMed
description Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 E1A or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli.
format Text
id pubmed-1568054
institution National Center for Biotechnology Information
language English
publishDate 1991
record_format MEDLINE/PubMed
spelling pubmed-15680542006-09-18 Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist. Ragozzino, M M Kuo, A DeGregori, J Kohl, N Ruley, H E Environ Health Perspect Research Article Gene transfer experiments have defined limitations with regard to the ability of individual oncogenes to transform cultured cells to a tumorigenic state. The stable transformation of REF52 cells by either the ras or sis oncogenes requires the continuous expression of a second collaborating oncogene, such as adenovirus-5 E1A or SV40 large T-antigen. Our studies suggest that the function of the nuclear collaborators is to antagonize dominant growth controls which limit the ability of REF52 cells to proliferate in response to mitogenic stimuli. 1991-06 /pmc/articles/PMC1568054/ /pubmed/1837777 Text en
spellingShingle Research Article
Ragozzino, M M
Kuo, A
DeGregori, J
Kohl, N
Ruley, H E
Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title_full Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title_fullStr Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title_full_unstemmed Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title_short Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
title_sort mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1568054/
https://www.ncbi.nlm.nih.gov/pubmed/1837777
work_keys_str_mv AT ragozzinomm mechanismsofoncogenecooperationactivationandinactivationofagrowthantagonist
AT kuoa mechanismsofoncogenecooperationactivationandinactivationofagrowthantagonist
AT degregorij mechanismsofoncogenecooperationactivationandinactivationofagrowthantagonist
AT kohln mechanismsofoncogenecooperationactivationandinactivationofagrowthantagonist
AT ruleyhe mechanismsofoncogenecooperationactivationandinactivationofagrowthantagonist